Key Financial Data Of Group

Mochida Pharmaceutical Co.,Ltd. - Filing #7584015

Concept 2022-07-01 to
2022-09-30
As at
2022-09-30
2022-04-01 to
2022-09-30
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-09-30
2021-07-01 to
2021-09-30
2021-04-01 to
2021-09-30
Key financial data of group
Business results of group
Net sales
53,200,000,000 JPY
110,179,000,000 JPY
54,009,000,000 JPY
Ordinary profit (loss)
5,443,000,000 JPY
14,799,000,000 JPY
6,377,000,000 JPY
Profit (loss) attributable to owners of parent
3,923,000,000 JPY
10,569,000,000 JPY
4,916,000,000 JPY
Comprehensive income
3,389,000,000 JPY
7,619,000,000 JPY
3,863,000,000 JPY
Net assets
129,222,000,000 JPY
128,646,000,000 JPY
128,921,000,000 JPY
Total assets
160,243,000,000 JPY
163,139,000,000 JPY
162,357,000,000 JPY
Basic earnings (loss) per share
20.52
104.62
277.39
59.13
128.47
Diluted earnings per share
Equity-to-asset ratio
0.806 xbrli:pure
0.789 xbrli:pure
0.794 xbrli:pure
Net cash provided by (used in) operating activities
5,174,000,000 JPY
7,459,000,000 JPY
2,891,000,000 JPY
Net cash provided by (used in) investing activities
-2,139,000,000 JPY
-2,007,000,000 JPY
-666,000,000 JPY
Net cash provided by (used in) financing activities
-2,816,000,000 JPY
-5,956,000,000 JPY
-1,915,000,000 JPY
Cash and cash equivalents
40,804,000,000 JPY
40,515,000,000 JPY
41,299,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.